Bio-Connect

ETS2 antibody

GTX104527
GeneTex
ApplicationsImmunoFluorescence, ImmunoPrecipitation, Western Blot, ChIP Chromatin ImmunoPrecipitation, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
TargetETS2
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    ETS2 antibody
  • Delivery Days Customer
    9
  • Application Supplier Note
    WB: 1:500-1:3000. ICC/IF: 1:100-1:1000. IHC-P: 1:100-1:1000. IP: 1:100-1:500. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
  • Applications
    ImmunoFluorescence, ImmunoPrecipitation, Western Blot, ChIP Chromatin ImmunoPrecipitation, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
  • Certification
    Research Use Only
  • Clonality
    Polyclonal
  • Concentration
    0.35 mg/ml
  • Conjugate
    Unconjugated
  • Gene ID2114
  • Target name
    ETS2
  • Target description
    ETS proto-oncogene 2, transcription factor
  • Target synonyms
    ETS2IT1, protein C-ets-2, oncogene ETS-2, v-ets avian erythroblastosis virus E2 oncogene homolog 2, v-ets avian erythroblastosis virus E26 oncogene homolog 2, v-ets erythroblastosis virus E26 oncogene homolog 2
  • Host
    Rabbit
  • Isotype
    IgG
  • Protein IDP15036
  • Protein Name
    Protein C-ets-2
  • Scientific Description
    ETS transcriptions factors, such as ETS2, regulate numerous genes and are involved in stem cell development, cell senescence and death, and tumorigenesis. The conserved ETS domain within these proteins is a winged helix-turn-helix DNA-binding domain that recognizes the core consensus DNA sequence GGAA/T of target genes (Dwyer et al., 2007 [PubMed 17986575]).[supplied by OMIM]
  • Storage Instruction
    -20°C or -80°C,2°C to 8°C
  • UNSPSC
    12352203

References

  • Kishimoto Y, Nishiura I, Hirata W, et al. A novel tissue specific alternative splicing variant mitigates phenotypes in Ets2 frame-shift mutant models. Sci Rep. 2021,11(1):8297. doi: 10.1038/s41598-021-87751-5
    Read this paper
  • Gluck C, Glathar A, Tsompana M, et al. Molecular dissection of the oncogenic role of ETS1 in the mesenchymal subtypes of head and neck squamous cell carcinoma. PLoS Genet. 2019,15(7):e1008250. doi: 10.1371/journal.pgen.1008250
    Read this paper
  • Helbig S, Wockner L, Bouendeu A, et al. Functional dissection of breast cancer risk-associated TERT promoter variants. Oncotarget. 2017,8(40):67203-67217. doi: 10.18632/oncotarget.18226
    Read this paper
  • Yuan J, Jiang YY, Mayakonda A, et al. Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma. Cancer Res. 2017,77(23):6614-6626. doi: 10.1158/0008-5472.CAN-17-1143
    Read this paper